Mitsubishi UFG-Akamai JV To Offer Digital Payment Services
Zacks Investment Research | Feb 12, 2019 09:28PM ET
Mitsubishi UFG Financial Group (NYSE:MUFG) recently announced that it has entered into a joint venture (JV) with Akamai Technologies (NASDAQ:AKAM) to form a new entity — the Global Open Network, Inc. (GO-NET). The companies plan to offer a new blockchain-based payment network through GO-NET.
The new payment network is expected to be made available in Japan in the first half of 2020. GO-NET will provide an extensive set of services, including support for existing payment-processing functions, micropayments, pay-per-use, and other developing IoT-enabled payment transactions.
"This joint venture with MUFG sets the stage for a new blockchain-based online payment system that can better serve customers' and partners' payment processing needs," said Dr. Tom Leighton, CEO and co-founder of Akamai Technologies.
MUFG will provide the know-how of financial services and expertise in business development to bring viable growth and success to the JV. Moreover, GO-NET will benefit from Akamai Technologies’ experience in building Blockchain as a service technology.
To power the online payment network, Akamai Technologies' globally distributed Intelligent Edge Platform will support its blockchain. Further, Akamai Technologies’ market-leading cloud security will secure transactions executed on the platform.
"Financial services need to embrace digital innovation to meet greater demands for security, capacity and efficiencies, and to serve evolving market and consumer needs," said Hironori Kamezawa, group CDTO of MUFG and CEO of GO-NET.
MUFG’s shares have lost 27.2% over the past year compared with the industry ’s decline of 14.8%.
MUFG currently carries Zacks Rank #3 (Hold). You can see
Key Picks
Banco Bradesco SA (NYSE:BBD) sports a Zacks Rank #1 (Strong Buy), at present. Its shares have rallied 65% in the past six months.
Banco Santander (MC:SAN) Brasil SA (NYSE:BSBR) flaunts a Zacks Rank of 1, currently. Its shares have gained 47% over the past six months.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Get The News You Want
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.